Cargando…

DNA testing for high risk of prostate cancer

Detalles Bibliográficos
Autor principal:	Wokołorczyk, Dominika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287432/ http://dx.doi.org/10.1186/1897-4287-10-S1-A12

Ejemplares similares

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

NBS1 Mutation and prognosis of prostate cancer
por: Wokołorczyk, Dominika, et al.
Publicado: (2012)

HOXB13 mutations and prostate cancer in Poland
por: Kluźniak, Wojciech, et al.
Publicado: (2012)

Progress in clinical genetics of prostate cancer
por: Cybulski, C, et al.
Publicado: (2011)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

New diagnostic test for high risk of breast cancer in Poland
por: Gorski, B
Publicado: (2011)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Focal MR-guided focused ultrasound treatment of localized low-risk prostate cancer
por: Nosov, Alexandr, et al.
Publicado: (2014)

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)
por: Kurzawski, G, et al.
Publicado: (2012)

Genome-proteome system for prostate cancer
por: Peshkov, Maxim N
Publicado: (2014)

Prostatic mapping in diagnosis and follow-up for prostatic cancer patients treated by CT-RT
por: Azzarello, Guido, et al.
Publicado: (2009)

Are women at high risk for serous gynaecological cancer (SGC) opting for risk-reducing salphingo-oophorectomy motivated by high levels of anxiety and risk perceptions?
por: Meiser, B, et al.
Publicado: (2012)

How high risk are 'high-risk' surgical patients?
por: Gomersall, CD, et al.
Publicado: (2003)

Interaction of prostate cancer and neurons – the neuro-neoplastic synapse
por: Voss, MJ, et al.
Publicado: (2009)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers
por: Deb, S, et al.
Publicado: (2012)

Serum levels of markers in early detection of prostate cancer (pilote study)
por: Fuchsova, Radka, et al.
Publicado: (2014)

High-risk breast cancer patients: comparison of lymphocyte phenotypes and function in vitro
por: Mohrmann, S, et al.
Publicado: (2001)

Transport of the high-risk neonate
por: Messner, Hubert, et al.
Publicado: (2015)

High incidence of positive fungal DNA in the blood of critically ill patients
por: Ikegami, K, et al.
Publicado: (2000)

Heme oxygenase-1 activation inhibits XMRV pathogenesis and carcinogenesis in prostate cancer cells
por: Dhawan, Subhash
Publicado: (2011)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

Primary prevention of breast cancer in high-risk women by monitoring epigenetic changes in nipple aspirates
por: van Diest, PJ, et al.
Publicado: (2009)

Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer
por: Trejo-Vázquez, Fabiola, et al.
Publicado: (2007)

High risk patients in major thoracic surgery
por: Della Rocca, G, et al.
Publicado: (1999)

Disk battery ingestion: high clinic risk
por: Di Pietro, Pasquale, et al.
Publicado: (2015)

Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction
por: Cetina, Lucely, et al.
Publicado: (2007)

Disruption of DNA methylation via S-adenosylhomocysteine is a key process in high incidence liver carcinogenesis
por: Mirbahai, Leda, et al.
Publicado: (2013)

The effects of XMRV gene expression on the mouse prostate
por: Rauch, Daniel, et al.
Publicado: (2011)

Postoperative morphine clonidine analgesia in high-risk patients
por: Bernikova, SV, et al.
Publicado: (2002)

Patterns of cytokines and lymphocyte subsets in patients with breast and prostate cancer treated with a standardized mistletoe extract preparation
por: Wetzel, D, et al.
Publicado: (2001)

Expression of hbz mRNA promotes survival in HTLV-1-infected cells with high DNA damage
por: Flores, Karina, et al.
Publicado: (2011)

Looking for RED FLAGS: identifying and supporting patients at risk of adverse psychological responses to genetic counselling and testing
por: Buscombe, S
Publicado: (2012)

Selenium and risk of bladder cancer
por: Złowocka-Perłowska, E, et al.
Publicado: (2012)

Arsenic (As) and breast cancer risk
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Selenium and gastrointestinal cancers risk
por: Lener, Marcin, et al.
Publicado: (2012)

Zinc and breast cancer risk
por: Kaczmarek, Katarzyna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fhr3ud9pgtr8cuh1qcm1jvvmt9